News
The two-midnight rule has the potential to increase hospital revenues from observation status patients but that revenue will be offset by shorter inpatient stays.
CareFirst BlueCross BlueShield is dishing out $1.5 million in telemedicine grants to help healthcare providers reach people with behavioral health issues with an eye towards improving adherence to their treatments and appointments.
President Obama went on the offensive to defend the benefits of the Affordable Care Act amid a rollout of the federal government's insurance marketplace website that has been disappointing, at best, at the same time that he assembles a sort of health tech dream team to fix the problems before it's too late.
WellPoint is taking a tough stance to try to combat prescription drug abuse and fraud activities that bubble to the surface through predictive analytics and other data runs of its members and their providers and pharmacies.
McKesson Corp. is settling allegations of drug pricing inflation with Virginia Medicaid, in one of the largest such recoveries for a state.
Three weeks after the disastrous launch of its health insurance marketplace, the Obama administration has vowed to redouble its efforts to fix its many glitches, promising a 'tech surge' to iron out its problems and improve the customer experience.
In the revenue cycle management market, hospitals show high adoption of technology focused on eligibility and scheduling, with much work left to be done around charity screening and propensity to pay, according to a new report from HIMSS Analytics.
Eliminating a traditional management exercise as old as the budget may seem risky to hospital CFOs, but many businesses have done just that. Some say using a 19th-century tool to manage a 21st-century organization makes little sense.
If we are to reduce health disparities in the U.S., we will have to do a better job of primary prevention. Investments in certain "social determinants of health" represent an underappreciated approach to this problem.
The hospital chargemaster assumed a new role in 2013 – that of a villain in the story of the already high and growing costs of healthcare. But it may be a case of miscasting.